Exchange: NASDAQ·Updated 07:52 PM EDT
ADPT logo

ADPT Adaptive Biotechnologies Corp

$24.28
$0.29
(1.18%)
Today
Closed $24.28
$0.19
(0.78%)
After Hours
EarningsNov 4
Mkt Cap$3.87B
Vol1.4M

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
58

Bullish Sentiment

How do you feel about ADPT?

Advertisement|Remove ads.